Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Mar 26 2003
WASHINGTON, D.C. (March 26, 2003) - J. Leighton Read, M.D., general partner of venture capital firm Alloy Ventures and former executive committee member of the...
Mar 25 2003
WASHINGTON, D.C. (March 25, 2003) – Next month’s BIO-Windhover 2003 conference in Washington, D.C. will highlight the key issues biotech companies face in...
Mar 24 2003
WASHINGTON, D.C. (March 24, 2003)- Venture capitalists nationwide will explore biotechnology investment opportunities in the Midwest at the BIO Mid-America...
Mar 20 2003
WASHINGTON, D.C. (March 20, 2003)— The Biotechnology Industry Organization (BIO) today announced that Stelios Papadopoulos, a leading expert in biotechnology...
Mar 12 2003
WASHINGTON, D.C. (March 12, 2003) – The Biotechnology Industry Organization (BIO) and the California Healthcare Institute (CHI) will host a breakfast,...
Mar 11 2003
WASHINGTON, D.C. (March 11, 2003)— The Biotechnology Industry Organization (BIO) today announced the list of start-up companies searching for private...
Mar 6 2003
WASHINGTON, D.C. (March 6, 2003)—The Biotechnology Industry Organization (BIO) in collaboration with eight Midwestern states and the Midwestern Health...
Feb 28 2003
Washington, D.C. (February 27, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the...
Feb 27 2003
New York (February 27, 2003) – The Biotechnology Industry Organization (BIO) and Long Island Life Sciences Initiative (LILSI) announced today the...


Biotechnology News

September 22, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX), a diversified, global medical device company focused on improving patients’ lives by...

September 22, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced the U.S. launch of Anacor’s FDA-approved drug KERYDINTM (tavaborole)...

September 22, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing...

September 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (OTCBB: XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel...

September 22, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--International Headache Meeting Presentation by electroCore - gammaCore therapy reduces cluster headache by 50%